Murex Investments

About The Fund

Murex Investments is an investment firm founded in 1998, managing a family of four investment funds, with a focus on aggressively-growing small businesses and middle-market companies that present considerable potential for growth, job creation, and retention. The firm consists of the following funds: Murex Investments I, LP, which is unique in the region as the sole SBA-licensed New Markets Venture Capital Company, is interested in later-stage companies within traditional industries. Then there is Murex Investments II, LP, which aligns with the strategic approach of the first fund but concentrates its investments within the State of Delaware. Murex Investments III, LP, which is in the process of formation, aims to deliver equity and mezzanine financing to middle-market industrial, distribution, business service, and healthcare companies. Their fourth fund, Murex Patient Capital Fund, supplies mezzanine financing to robust businesses that contribute to employment and wealth increase, especially looking at companies on the smaller end of the middle market. Murex Investments targets their investments in companies with defined exit strategies, considering a range of criteria that include early to succession-stage companies and revenue between $1,000,000 to $20,000,000. They are not only selective in the companies they finance but also stage their investments through multiple financings, to effectively manage risk, with individual company investments typically ranging from $500,000 to $2,000,000. Despite their diverse fund strategies, all efforts are united by their investment in IT and TMT industries, as well as other sectors. However, their current website indicates that the domain is available for purchase, suggesting potential changes or transitions within the company's web presence.